Biologics Contract Manufacturing Global and China Top Players Market

Biologics Contract Manufacturing - Global and China Top Players Market Share and Ranking 2025

Biologics Contract Manufacturing Global and China Top Players Market

Biologics Contract Manufacturing - Global and China Top Players Market Share and Ranking 2025

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Ample Market Research presents an in-depth analysis of the Biologics Contract Manufacturing Market, offering valuable insights into current industry trends, future growth prospects, and strategic market dynamics. This report provides a detailed evaluation of key market drivers, restraints, emerging trends, and regional influences shaping the industry's evolution.

By leveraging historical analysis and forecast projections, this study offers a holistic understanding of market developments, assisting stakeholders in making informed strategic decisions. Additionally, a SWOT analysis is incorporated to highlight strengths, weaknesses, opportunities, and threats within the sector.

The evolving U.S. tariff policy in 2025 is bringing considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the world, assessing their impacts on Biologics Contract Manufacturing market competitiveness, regional economic interdependencies, and supply chain reconfigurations.

Biologics Contract Manufacturing Market Segmentation
Market segmentation in research is the process of breaking down a broad market into distinct consumer groups based on shared characteristics, such as demographics, geographic location, behavioral patterns, or lifestyle preferences. This approach enables businesses to refine their product offerings and marketing strategies to better address the unique needs of each segment. By tailoring their approach, companies can optimize resource allocation, enhance customer satisfaction, and drive sales growth, ultimately securing a competitive advantage. Effective segmentation helps businesses gain deeper insights into their audience, craft targeted strategies, and maximize overall market performance.

Biologics Contract Manufacturing Market by Type [Analysis by Value from 2020 to 2031]:
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Molecular Therapy
  • Others


Biologics Contract Manufacturing Market by Application [Analysis by Value from 2020 to 2031]:
  • Medical Company
  • Hospital


Key Players in the Biologics Contract Manufacturing Market
Leading market players are focused on strengthening their presence by acquiring emerging companies. Established firms are heavily investing in research and development to introduce innovative products and expand their market reach. Additionally, some companies are engaging in mergers to leverage their combined strengths and deliver high-quality products. Based on these factors, the study includes the following key industry players.
  • Lonza Group
  • Samsung Biologics Co., Ltd.
  • Thermo Fisher Scientific, Inc.
  • Cambrex Corporation
  • Siegfried Holding AG
  • Fujifilm Holding Corporation
  • AbbVie, Inc.
  • Boehringer Ingelheim
  • Recipharm Pharmaceuticals
  • WuXi Biologics
  • Catalent, Inc.


Biologics Contract Manufacturing Market Dynamics: Drivers & Restraints
The report meticulously examines the core growth factors and challenges influencing market expansion. Each variable is supported by qualitative and quantitative insights, with Harvey ball indicators representing their level of impact.

Biologics Contract Manufacturing Market Analysis & Industry Trends
A comprehensive overview of industry developments, regulatory updates, and structural market shifts is provided. The report also evaluates the impact of U.S. tariff policy on global demand fluctuations and recovery patterns.

Biologics Contract Manufacturing Market Size & Demand Forecast (2031)
Precise market sizing data and demand forecasts are included, covering year-on-year (YoY) growth rates and compound annual growth rate (CAGR) projections, enabling businesses to plan for future growth.

Biologics Contract Manufacturing Industry Supply Chain & Competitive Analysis
Using Porter’s Five Forces framework, the report assesses competitive intensity and profitability within the industry. A detailed supply chain analysis examines market participants, operational structures, and efficiency factors.

Biologics Contract Manufacturing Segmentation & Growth Forecasts
The study systematically breaks down the Global Biologics Contract Manufacturing Market into multiple segments, outlining current conditions and future growth trajectories. This helps identify emerging trends and lucrative opportunities.

Regional Market Insights
The report offers country-wise assessments of market drivers, regulatory frameworks, and growth prospects across key regions:
• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Russia)
• Asia-Pacific (China, India, Japan, South Korea, Australia)
• Rest of the World (Saudi Arabia, Brazil, Nigeria, South Africa)

Competitive Landscape & Key Player Profiles

Detailed evaluations of major companies include:
• Business overview & product offerings
• Financial performance & investment trends
• Recent mergers, acquisitions, and joint ventures (JVs)
• Strategic approaches adopted by market leaders

Executive Summary & Actionable Recommendations
A concise summary featuring charts, infographics, and forward-looking forecasts is provided. The report concludes with strategic recommendations to guide market stakeholders in decision-making.

Why Invest in This Biologics Contract Manufacturing Market Report?
✔️ Gain valuable insights into how COVID-19 has influenced the Biologics Contract Manufacturing market.
✔️ Discover market opportunities across key global regions.
✔️ Evaluate growth drivers & restraints and their long-term impact.
✔️ Access comprehensive market sizing & forecasting data.
✔️ Stay ahead of industry trends & competitive strategies.
✔️ Monitor M&A activities, partnerships, and joint ventures shaping the market.

For expert insights and customized segmentation, contact us to tailor the report to your specific business needs.

1 Market Overview

1.1 Biologics Contract Manufacturing Definition

1.2 Global Biologics Contract Manufacturing Market Size and Forecast

1.3 China Biologics Contract Manufacturing Market Size and Forecast

1.4 Share of China Biologics Contract Manufacturing Market with Respect to the Global Market

1.5 Biologics Contract Manufacturing Market Size: China VS Global Growth Rate, 2020-2031

1.6 Biologics Contract Manufacturing Market Dynamics

1.6.1 Biologics Contract Manufacturing Market Drivers

1.6.2 Biologics Contract Manufacturing Market Restraints

1.6.3 Biologics Contract Manufacturing Industry Trends

1.6.4 Biologics Contract Manufacturing Industry Policy

2 Global Leading Players and Market Share

2.1 By Revenue of Biologics Contract Manufacturing, Global Market Share by Company, 2020-2025

2.2 Global Biologics Contract Manufacturing Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.3 Global Biologics Contract Manufacturing Concentration Ratio

2.4 Global Biologics Contract Manufacturing Mergers & Acquisitions, Expansion Plans

2.5 Global Biologics Contract Manufacturing Major Companies Product Type

2.6 Head Office and Area Served of Key Players

3 China Leading Players, Market Share and Ranking

3.1 By Revenue of Biologics Contract Manufacturing, China Market Share by Company, 2020-2025

3.2 China Biologics Contract Manufacturing Biologics Contract Manufacturing Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis

4.1 Biologics Contract Manufacturing Industry Chain

4.2 Biologics Contract Manufacturing Upstream Analysis

4.2.1 Biologics Contract Manufacturing Core Raw Materials

4.2.2 Main Manufacturers of Biologics Contract Manufacturing Core Raw Materials

4.3 Midstream Analysis

4.4 Downstream Analysis

4.5 Biologics Contract Manufacturing Production Mode

4.6 Biologics Contract Manufacturing Procurement Model

4.7 Biologics Contract Manufacturing Industry Sales Model and Sales Channels

4.7.1 Biologics Contract Manufacturing Sales Model

4.7.2 Biologics Contract Manufacturing Typical Distributors

5 Sights by Type

5.1 Biologics Contract Manufacturing Classification

5.1.1 Monoclonal Antibodies

5.1.2 Recombinant Proteins

5.1.3 Vaccines

5.1.4 Molecular Therapy

5.1.5 Others

5.2 by Type, Global Biologics Contract Manufacturing Consumption Value & CAGR, 2020 VS 2024 VS 2031

5.3 by Type, Global Biologics Contract Manufacturing Consumption Value, 2020-2031

6 Sights by Application

6.1 Biologics Contract Manufacturing Segment by Application

6.1.1 Medical Company

6.1.2 Hospital

6.2 by Application, Global Biologics Contract Manufacturing Consumption Value & CAGR, 2020 VS 2024 VS 2031

6.3 by Application, Global Biologics Contract Manufacturing Consumption Value, 2020-2031

7 Sales Sights by Region

7.1 By Region, Global Biologics Contract Manufacturing Consumption Value, 2020 VS 2024 VS 2031

7.2 By Region, Global Biologics Contract Manufacturing Consumption Value, 2020-2031

7.3 North America

7.3.1 North America Biologics Contract Manufacturing Market Size & Forecasts, 2020-2031

7.3.2 By Country, North America Biologics Contract Manufacturing Market Size Market Share

7.4 Europe

7.4.1 Europe Biologics Contract Manufacturing Market Size & Forecasts, 2020-2031

7.4.2 By Country, Europe Biologics Contract Manufacturing Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Biologics Contract Manufacturing Market Size & Forecasts, 2020-2031

7.5.2 By Country/Region, Asia Pacific Biologics Contract Manufacturing Market Size Market Share

7.6 South America

7.6.1 South AmericaBiologics Contract Manufacturing Market Size & Forecasts, 2020-2031

7.6.2 By Country, South America Biologics Contract Manufacturing Market Size Market Share

7.7 Middle East & Africa

8 Sales Sights by Country Level

8.1 By Country, Global Biologics Contract Manufacturing Market Size & CAGR, 2020 VS 2024 VS 2031

8.2 By Country, Global Biologics Contract Manufacturing Consumption Value, 2020-2031

8.3 United States

8.3.1 United States Biologics Contract Manufacturing Market Size, 2020-2031

8.3.2 by Type, United States Biologics Contract Manufacturing Consumption Value Market Share, 2024 VS 2031

8.3.3 by Application, United States Biologics Contract Manufacturing Consumption Value Market Share, 2024 VS 2031

8.4 Europe

8.4.1 Europe Biologics Contract Manufacturing Market Size, 2020-2031

8.4.2 by Type, Europe Biologics Contract Manufacturing Consumption Value Market Share, 2024 VS 2031

8.4.3 by Application, Europe Biologics Contract Manufacturing Consumption Value Market Share, 2024 VS 2031

8.5 China

8.5.1 China Biologics Contract Manufacturing Market Size, 2020-2031

8.5.2 by Type, China Biologics Contract Manufacturing Consumption Value Market Share, 2024 VS 2031

8.5.3 by Application, China Biologics Contract Manufacturing Consumption Value Market Share, 2024 VS 2031

8.6 Japan

8.6.1 Japan Biologics Contract Manufacturing Market Size, 2020-2031

8.6.2 by Type, Japan Biologics Contract Manufacturing Consumption Value Market Share, 2024 VS 2031

8.6.3 by Application, Japan Biologics Contract Manufacturing Consumption Value Market Share, 2024 VS 2031

8.7 South Korea

8.7.1 South Korea Biologics Contract Manufacturing Market Size, 2020-2031

8.7.2 by Type, South Korea Biologics Contract Manufacturing Consumption Value Market Share, 2024 VS 2031

8.7.3 by Application, South Korea Biologics Contract Manufacturing Consumption Value Market Share, 2024 VS 2031

8.8 Southeast Asia

8.8.1 Southeast Asia Biologics Contract Manufacturing Market Size, 2020-2031

8.8.2 by Type, Southeast Asia Biologics Contract Manufacturing Consumption Value Market Share, 2024 VS 2031

8.8.3 by Application, Southeast Asia Biologics Contract Manufacturing Consumption Value Market Share, 2024 VS 2031

8.9 India

8.9.1 India Biologics Contract Manufacturing Market Size, 2020-2031

8.9.2 by Type, India Biologics Contract Manufacturing Consumption Value Market Share, 2024 VS 2031

8.9.3 by Application, India Biologics Contract Manufacturing Consumption Value Market Share, 2024 VS 2031

8.10 Middle East & Africa

8.10.1 Middle East & Africa Biologics Contract Manufacturing Market Size, 2020-2031

8.10.2 by Type, Middle East & Africa Biologics Contract Manufacturing Consumption Value Market Share, 2024 VS 2031

8.10.3 by Application, Middle East & Africa Biologics Contract Manufacturing Consumption Value Market Share, 2024 VS 2031

9 Company Profile

9.1 Lonza Group

9.1.1 Lonza Group Company Information, Head Office, Market Area, and Industry Position

9.1.2 Lonza Group Company Profile and Main Business

9.1.3 Lonza Group Biologics Contract Manufacturing Models, Specifications, and Application

9.1.4 Lonza Group Biologics Contract Manufacturing Revenue and Gross Margin, 2020-2025

9.1.5 Lonza Group Recent Developments

9.2 Samsung Biologics Co., Ltd.

9.2.1 Samsung Biologics Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

9.2.2 Samsung Biologics Co., Ltd. Company Profile and Main Business

9.2.3 Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Models, Specifications, and Application

9.2.4 Samsung Biologics Co., Ltd. Biologics Contract Manufacturing Revenue and Gross Margin, 2020-2025

9.2.5 Samsung Biologics Co., Ltd. Recent Developments

9.3 Thermo Fisher Scientific, Inc.

9.3.1 Thermo Fisher Scientific, Inc. Company Information, Head Office, Market Area, and Industry Position

9.3.2 Thermo Fisher Scientific, Inc. Company Profile and Main Business

9.3.3 Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Models, Specifications, and Application

9.3.4 Thermo Fisher Scientific, Inc. Biologics Contract Manufacturing Revenue and Gross Margin, 2020-2025

9.3.5 Thermo Fisher Scientific, Inc. Recent Developments

9.4 Cambrex Corporation

9.4.1 Cambrex Corporation Company Information, Head Office, Market Area, and Industry Position

9.4.2 Cambrex Corporation Company Profile and Main Business

9.4.3 Cambrex Corporation Biologics Contract Manufacturing Models, Specifications, and Application

9.4.4 Cambrex Corporation Biologics Contract Manufacturing Revenue and Gross Margin, 2020-2025

9.4.5 Cambrex Corporation Recent Developments

9.5 Siegfried Holding AG

9.5.1 Siegfried Holding AG Company Information, Head Office, Market Area, and Industry Position

9.5.2 Siegfried Holding AG Company Profile and Main Business

9.5.3 Siegfried Holding AG Biologics Contract Manufacturing Models, Specifications, and Application

9.5.4 Siegfried Holding AG Biologics Contract Manufacturing Revenue and Gross Margin, 2020-2025

9.5.5 Siegfried Holding AG Recent Developments

9.6 Fujifilm Holding Corporation

9.6.1 Fujifilm Holding Corporation Company Information, Head Office, Market Area, and Industry Position

9.6.2 Fujifilm Holding Corporation Company Profile and Main Business

9.6.3 Fujifilm Holding Corporation Biologics Contract Manufacturing Models, Specifications, and Application

9.6.4 Fujifilm Holding Corporation Biologics Contract Manufacturing Revenue and Gross Margin, 2020-2025

9.6.5 Fujifilm Holding Corporation Recent Developments

9.7 AbbVie, Inc.

9.7.1 AbbVie, Inc. Company Information, Head Office, Market Area, and Industry Position

9.7.2 AbbVie, Inc. Company Profile and Main Business

9.7.3 AbbVie, Inc. Biologics Contract Manufacturing Models, Specifications, and Application

9.7.4 AbbVie, Inc. Biologics Contract Manufacturing Revenue and Gross Margin, 2020-2025

9.7.5 AbbVie, Inc. Recent Developments

9.8 Boehringer Ingelheim

9.8.1 Boehringer Ingelheim Company Information, Head Office, Market Area, and Industry Position

9.8.2 Boehringer Ingelheim Company Profile and Main Business

9.8.3 Boehringer Ingelheim Biologics Contract Manufacturing Models, Specifications, and Application

9.8.4 Boehringer Ingelheim Biologics Contract Manufacturing Revenue and Gross Margin, 2020-2025

9.8.5 Boehringer Ingelheim Recent Developments

9.9 Recipharm Pharmaceuticals

9.9.1 Recipharm Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

9.9.2 Recipharm Pharmaceuticals Company Profile and Main Business

9.9.3 Recipharm Pharmaceuticals Biologics Contract Manufacturing Models, Specifications, and Application

9.9.4 Recipharm Pharmaceuticals Biologics Contract Manufacturing Revenue and Gross Margin, 2020-2025

9.9.5 Recipharm Pharmaceuticals Recent Developments

9.10 WuXi Biologics

9.10.1 WuXi Biologics Company Information, Head Office, Market Area, and Industry Position

9.10.2 WuXi Biologics Company Profile and Main Business

9.10.3 WuXi Biologics Biologics Contract Manufacturing Models, Specifications, and Application

9.10.4 WuXi Biologics Biologics Contract Manufacturing Revenue and Gross Margin, 2020-2025

9.10.5 WuXi Biologics Recent Developments

9.11 Catalent, Inc.

9.11.1 Catalent, Inc. Company Information, Head Office, Market Area, and Industry Position

9.11.2 Catalent, Inc. Company Profile and Main Business

9.11.3 Catalent, Inc. Biologics Contract Manufacturing Models, Specifications, and Application

9.11.4 Catalent, Inc. Biologics Contract Manufacturing Revenue and Gross Margin, 2020-2025

9.11.5 Catalent, Inc. Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Biologics Contract Manufacturing Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Ample Market Reports Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Ample Market Reports Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the Biologics Contract Manufacturing Market trending toward high growth trajectories?
A dynamic process in the Biologics Contract Manufacturing Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like Lonza Group Samsung Biologics Co., Ltd. Thermo Fisher Scientific, Inc. Cambrex Corporation Siegfried Holding AG Fujifilm Holding Corporation AbbVie, Inc. Boehringer Ingelheim Recipharm Pharmaceuticals WuXi Biologics Catalent, Inc..
How competitive is the Biologics Contract Manufacturing Market going to be?
The strategic moves of the Biologics Contract Manufacturing Market players such as Lonza Group Samsung Biologics Co., Ltd. Thermo Fisher Scientific, Inc. Cambrex Corporation Siegfried Holding AG Fujifilm Holding Corporation AbbVie, Inc. Boehringer Ingelheim Recipharm Pharmaceuticals WuXi Biologics Catalent, Inc., and others clearly highlight consumer-centric strategies that use technology to improve customer experience.
Who are the significant end-users in the Biologics Contract Manufacturing Market?
The key end-users in the Biologics Contract Manufacturing Market are Medical Company Hospital
What is the market value of the Biologics Contract Manufacturing Industry?
In 2024, the Biologics Contract Manufacturing Market share exceeded USD xx million. Between 2025 and 2030, it will grow at a CAGR of yy%.
What is Biologics Contract Manufacturing Market Concentration Rate?
In addition to the Biologics Contract Manufacturing Market share analysis by competitors, the report also includes chapters on the HHI Index, CR4, and CR8 to characterize the concentration rate and competitive character of the Biologics Contract Manufacturing Market.
What is the estimated global market value of the Biologics Contract Manufacturing Market?
The Biologics Contract Manufacturing Market is expected to reach a considerable market valuation.